Skip to product information

Quick Facts

MK-677 (Ibutamoren) is a highly potent, orally active, non-peptide Growth Hormone Secretagogue. Itperfectly mimics the hunger hormone ghrelin, binding to receptors in the brain to stimulate a massive,sustained, 24-hour release of endogenous Human Growth Hormone (hGH) and IGF-1. Known for itsunparalleled convenience, it drives profound muscular hypertrophy, rapid injury repair, drasticallyincreased bone density, and deep, neuro-restorative sleep without the need for subcutaneousinjections.

Generic Name
Ibutamoren (MK-677)
Drug Class
Non-Peptide Growth Hormone Secretagogue (Ghrelin Agonist)
Administration
Oral (Liquid Suspension or Capsule)
FDA Approval
Investigational (Orphan drug designation for GH deficiency)
Typical Maintenance Dose
10mg to 25mg daily
Starting Dose
10mg daily (Morning for hunger, Night to avoid hunger)
Injection Sites
N/A (Oral administration)
Treatment Duration
Long-term cycles (3 to 12 months)
Storage
Room temperature, away from direct sunlight
Prescription Required
Yes (Often compounded)
Average Outcome
Massive IGF-1 elevation, lean mass gain, improved sleep architecture
Best For
Hypertrophy, anti-aging, injury recovery, needle-averse patients

What Is MK-677 ?

MK-677, also known as Ibutamoren, is an orally active growth hormone secretagogue that stimulates the body's natural production of Growth Hormone (GH) and Insulin-Like Growth Factor-1 (IGF-1). Rather than supplying synthetic growth hormone, MK-677 mimics the hormone ghrelin by activating the Growth Hormone Secretagogue Receptor (GHSR-1a) in the brain, promoting sustained GH release while preserving the body's natural endocrine function. Because of its long half-life, a single daily dose can maintain elevated GH and IGF-1 levels for approximately 24 hours. MK-677 has been investigated for its potential to support lean muscle mass, bone density, recovery, sleep quality, and metabolic health. Unlike injectable peptide secretagogues, MK-677 is administered orally, making it convenient for research and clinical investigation. However, MK-677 is not approved by the U.S. FDA for general medical use and remains an investigational compound. Ongoing research continues to evaluate its long-term safety, efficacy, and potential therapeutic applications.

Introduction: The Distinction Between Peptides and Oral Secretagogues

In the rapidly expanding world of regenerative medicine, hormone optimization, and performance enhancement, MK-677 (Ibutamoren) occupies a unique and highly celebrated position. While it is frequently grouped into the category of "muscle growth, performance, and GH peptides" for search relevance and categorical simplicity, it is crucial to establish right away that MK-677 is not actually a peptide. Peptides are short chains of amino acids that are typically destroyed by stomach acid, requiring subcutaneous injection to bypass the digestive tract. MK-677, however, is a non-peptide spiroindoline compound. This fundamental structural difference grants it a monumental advantage: it is fully orally bioavailable. You do not inject MK-677; you swallow it. Despite this structural difference, its biological purpose aligns perfectly with the peptide family: it acts as a highly potent, long-acting Growth Hormone Secretagogue (GHS). By mimicking the hunger hormone ghrelin, it signals the pituitary gland to secrete massive, sustained pulses of endogenous Human Growth Hormone (hGH), making it one of the most accessible and effective tools for systemic regeneration, hypertrophy, and anti-aging.

The Ghrelin Receptor and the Mechanism of Action

To understand the profound physiological impact of MK-677, one must examine its interaction with the endocrine system. The body possesses a specific receptor known as the Growth Hormone Secretagogue Receptor (GHSR-1a), which is primarily concentrated in the hypothalamus and the anterior pituitary gland. The natural ligand (the "key") for this receptor is ghrelin, a hormone produced in the stomach that regulates appetite and energy distribution. MK-677 was engineered to be a perfect synthetic key for this lock. When ingested, it crosses the blood-brain barrier and binds tightly to the GHSR-1a. This binding flips a biological switch, triggering a cascade of intracellular signaling that forces the somatotroph cells of the pituitary gland to release their stored reserves of growth hormone into the bloodstream. Because it acts on the ghrelin pathway, MK-677 bypasses the somatostatin "brake" that normally inhibits GH release, resulting in a continuous, high-amplitude signaling environment that drastically elevates systemic growth hormone levels.

The 24-Hour Half-Life and Sustained IGF-1 Elevation

One of the most defining characteristics of MK-677, which sets it apart from almost every injectable Growth Hormone Releasing Peptide (GHRP), is its extraordinarily long half-life. While injectable peptides like Ipamorelin or GHRP-2 have half-lives measured in minutes, requiring multiple daily injections to maintain elevated hormone levels, MK-677 has a half-life of approximately 24 hours. A single oral dose provides a sustained, day-long elevation in growth hormone pulsing. As this growth hormone circulates, it passes through the liver, where it stimulates a massive and continuous production of Insulin-Like Growth Factor 1 (IGF-1). Clinical studies have consistently demonstrated that a once-daily dose of MK-677 can elevate systemic IGF-1 levels by anywhere from 40% to 80%, keeping the body in a state of hyper-anabolism around the clock. This sustained elevation is the primary driver behind the compound's profound capacity for tissue repair and muscle growth.

Muscular Hypertrophy, Nitrogen Retention, and Anti-Catabolism

For athletes, bodybuilders, and those recovering from severe physical trauma, MK-677 represents a holy grail of oral anabolism. The sustained elevation of IGF-1 acts directly on skeletal muscle tissue. IGF-1 is arguably the most potent anabolic hormone in the human body; it drastically upregulates the rate of intracellular protein synthesis while simultaneously inhibiting protein breakdown. In clinical trials, MK-677 has been proven to reverse diet-induced nitrogen wasting—a metabolic state where the body cannibalizes its own muscle tissue for energy. By shifting the body into a state of positive nitrogen balance, MK-677 ensures that dietary protein is efficiently partitioned into building new muscle fibers. Furthermore, IGF-1 stimulates the proliferation of satellite cells, which fuse with existing muscle fibers to increase their contractile density, allowing users to pack on significant, highly functional lean muscle mass.

Bone Mineral Density and Skeletal Remodeling

While muscle tissue responds rapidly to hormonal shifts, the skeletal system remodels at a much slower pace. However, the long-term benefits of MK-677 on bone mineral density are among its most well-documented clinical outcomes. Growth hormone and IGF-1 are the master regulators of osteogenesis (bone formation). MK-677 stimulates the activity of osteoblasts, the cells responsible for laying down new bone matrix. Interestingly, clinical trials show that in the initial stages of MK-677 therapy, markers of bone resorption (breakdown) actually increase alongside markers of bone formation. This indicates a massive acceleration in total bone turnover—the old, brittle bone is rapidly cleared away to make room for new, dense, highly mineralized bone. After 12 to 24 months of continuous therapy, patients demonstrate highly significant improvements in overall bone mineral density, making MK-677 a powerful weapon against age-related osteopenia, osteoporosis, and athletic stress fractures.

Sleep Architecture and Neurological Recovery

The impact of MK-677 on sleep quality is immediate, profound, and often cited by users as its most life-changing benefit. Growth hormone production is inextricably linked to sleep, with the body’s natural pulses occurring during the deepest phases of rest. MK-677 drastically alters sleep architecture by significantly extending the duration of Stage 3 Slow-Wave Sleep (deep sleep) and REM sleep. Clinical studies have shown that MK-677 can increase deep sleep duration by up to 50% in both young and older adults. This deep sleep phase is the critical biological window during which the brain flushes out neurotoxic waste, repairs central nervous system fatigue, and consolidates memory. Patients taking MK-677 routinely report waking up feeling intensely refreshed, with a total resolution of systemic fatigue and brain fog, regardless of intense physical training the day before.

The "Hunger Surge": Harnessing the Ghrelin Mimetic

Because MK-677 is a direct ghrelin receptor agonist, it triggers the exact same neurological pathways that signal starvation and appetite. For many users, this manifests as a profound, intense surge in hunger shortly after dosing. While this might be viewed as a negative side effect for individuals attempting to lose weight, it is an invaluable pharmacological tool for athletes in a "bulking" phase, individuals suffering from cachexia (muscle wasting), or older adults experiencing age-related appetite loss. By chemically overriding the body's satiety signals, MK-677 allows users to easily consume the massive caloric surplus required to fuel extreme muscular hypertrophy. For those who wish to avoid this hunger, strategically timing the dose immediately before bed often allows the user to sleep through the appetite spike.

Nootropic Effects, Neuroprotection, and Cognitive Longevity

Beyond physical enhancement, MK-677 exhibits fascinating nootropic (cognitive-enhancing) properties. The brain is dense with IGF-1 receptors, and age-related cognitive decline is heavily correlated with the loss of endogenous growth hormone. By providing a sustained, 24-hour elevation in systemic IGF-1, MK-677 supports neurogenesis (the creation of new neurons) and enhances synaptic plasticity (the ability of the brain to form new connections). Furthermore, deep sleep—which MK-677 heavily promotes—is the primary mechanism by which the brain clears beta-amyloid plaques, the protein aggregates associated with Alzheimer's disease. By combining enhanced cerebral IGF-1 signaling with optimized slow-wave sleep, MK-677 acts as a formidable neuroprotective agent, preserving cognitive sharpness, memory recall, and overall executive function as we age.

Safety Profile: Preserving the Endocrine Feedback Loop

Unlike exogenous Human Growth Hormone (hGH), which suppresses the body’s natural hormone production, MK-677 functions as a growth hormone secretagogue that stimulates the pituitary gland to release endogenous growth hormone. By working within the body’s natural endocrine feedback system, MK-677 helps maintain physiological hormone regulation without causing pituitary shutdown or long-term dependency. As growth hormone levels rise, the body’s built-in regulatory mechanisms, including somatostatin release, naturally moderate further secretion. This physiological approach makes MK-677 an attractive option for individuals seeking long-term growth hormone optimization while preserving normal endocrine function. Under appropriate medical supervision, many users incorporate MK-677 into extended protocols lasting several months without disrupting the body's natural hormonal production.

Managing Insulin Sensitivity and Water Retention

Because MK-677 produces sustained elevations in growth hormone and IGF-1, users may experience temporary increases in water retention during the early stages of supplementation. Growth hormone can also influence glucose metabolism, making insulin sensitivity an important consideration during prolonged use. Maintaining a balanced diet, engaging in regular physical activity, and monitoring blood glucose levels may help support overall metabolic health throughout therapy. Some healthcare providers may recommend additional lifestyle strategies or adjunctive therapies when clinically appropriate. With responsible monitoring and individualized guidance, most users can effectively manage these temporary metabolic changes while continuing to benefit from MK-677’s anabolic and regenerative properties.

The Zenith of Oral Growth Hormone Optimization

MK-677 (Ibutamoren) has earned recognition as one of the most convenient oral growth hormone secretagogues available for research and clinical investigation. By stimulating the body's own production of growth hormone and increasing circulating IGF-1 levels, it supports muscle recovery, lean body composition, bone health, tissue regeneration, and restorative sleep without requiring injections. Its once-daily oral administration, long half-life, and sustained endocrine activity distinguish it from many injectable growth hormone secretagogues. Whether being explored for healthy aging, recovery support, or performance optimization under appropriate medical guidance, MK-677 represents an innovative approach to enhancing the body's natural regenerative pathways while preserving normal physiological hormone regulation.

MK-677 Research Studies

Published clinical and preclinical research on MK-677 .

Sustained 24-Hour IGF-1 Elevation

MK-677 Sustained 24-Hour IGF-1 Elevation

Clinical trials consistently demonstrate that a single oral dose of MK-677 produces a sustained, 24-hour elevation in systemic IGF-1 levels (frequently increasing baseline levels by 40% to 80%). This long half-life keeps the body in a continuous state of highly anabolic tissue repair.

Bone Mineral Density and Turnover

MK-677 Bone Mineral Density and Turnover

Bone Mineral Density and Turnover Extensive studies on aging populations confirm that long-term use of MK-677 (12+ months) significantly accelerates bone turnover and dramatically increases total bone mineral density, making it a highly researched compound for the treatment of osteoporosis and frailty.

Reversal of Diet-Induced Nitrogen Wasting

MK-677 Reversal of Diet-Induced Nitrogen Wasting

In controlled metabolic trials, subjects placed on severe caloric deficits who were administered MK-677 completely reversed their nitrogen wasting (muscle catabolism). The secretagogue forces the body to preserve lean muscle tissue even under extreme dietary stress.

MK-677 vs Other Peptides

How does MK-677 compare to other leading research peptides?

FeatureMK-677 (IBUTAMOREN)IPAMORELIN (GHRP)SYNTHETIC EXOGENOUS HGH
StructureNon-Peptide (Oral)Peptide (Injection)Hormone (Injection)
Half-LifeVery Long (~24 hours)Very Short (~2 hours)Prolonged systemic
Appetite StimulationHigh (Ghrelin Mimetic)None to MildNone
Pituitary SuppressionNo (Preserves naturalfunction)No (Preserves naturalfunction)Yes (Severeshutdown)
Water Retention RiskModerate to HighModerate to HighHigh
Insulin ImpactCan lower sensitivityMinimalCan lower sensitivity

MK-677 vs Ipamorelin

  • Both increase endogenous growth hormone (GH) and Insulin-Like Growth Factor-1 (IGF-1), but they act through different mechanisms. MK-677 is an orally active ghrelin receptor agonist, while Ipamorelin is an injectable Growth Hormone Releasing Peptide (GHRP).
  • MK-677 has a long half-life that supports sustained GH and IGF-1 elevation over 24 hours, whereas Ipamorelin produces short, physiological pulses of GH release.
  • Ipamorelin is highly selective and has minimal effects on cortisol and prolactin, while MK-677 commonly increases appetite due to its ghrelin-mimicking activity.

MK-677 vs Tesamorelin

  • MK-677 and Tesamorelin both stimulate the body's natural growth hormone production but target different receptors. MK-677 activates the Growth Hormone Secretagogue Receptor (GHSR-1a), while Tesamorelin is a Growth Hormone-Releasing Hormone (GHRH) analog that stimulates GHRH receptors in the pituitary.
  • MK-677 is orally administered and provides prolonged GH stimulation, whereas Tesamorelin is administered by injection and promotes physiological pulsatile GH release.
  • Tesamorelin is FDA-approved for reducing excess visceral abdominal fat in adults with HIV-associated lipodystrophy, while MK-677 remains an investigational compound and is not FDA-approved for medical use.

PeptideValidation Testing & Validation

Every product undergoes rigorous multi-layer laboratory validation.

🔬

Medical History

MH

  • Review of any hormone-sensitive malignancies (as continuously elevated IGF-1 can theoretically stimulate existing tumor growth).
  • Current status of insulin sensitivity, fasting glucose, and history of Type 2 Diabetes or metabolic syndrome.
  • Baseline assessment of joint pain or edema, to distinguish from the intracellular water retention commonly caused by the compound.

🔬

Laboratory Testing

LT

  • Baseline IGF-1 (Insulin-Like Growth Factor 1) levels to establish current endogenous growth hormone status.
  • Fasting Blood Glucose and Hemoglobin A1c (HbA1c) – This is the most critical monitoring metric, as prolonged MK-677 use can alter glucose metabolism.
  • Prolactin and Cortisol levels (as aggressive ghrelin agonists can sometimes mildly elevate these).

🔬

Monitoring During Treatment

MDT

  • Follow-up IGF-1 testing 4 to 8 weeks into therapy to objectively measure the pituitary's response.
  • Frequent monitoring of fasting blood glucose (often daily or weekly at home) to ensure insulin sensitivity remains healthy.
  • Tracking of water retention, blood pressure, and sleep quality.

Frequently Asked Questions

Everything you need to know about peptide testing, certification, and compliance.

MK-677, also known as Ibutamoren, is an oral growth hormone secretagogue that stimulates the body's natural release of growth hormone (GH) and Insulin-Like Growth Factor-1 (IGF-1). Although often grouped with peptides, it is not a peptide.

It binds to ghrelin receptors in the brain, signaling the pituitary gland to release more natural growth hormone, which subsequently increases IGF-1 production in the liver.

Commonly reported benefits include increased GH and IGF-1 levels, improved recovery, better sleep quality, support for lean muscle growth, enhanced bone health, and improved overall tissue repair.

No. MK-677 is taken orally, usually once per day, making it more convenient than injectable growth hormone secretagogues.

MK-677 has a relatively long half-life of approximately 24 hours, allowing for once-daily dosing.

No. Although it is almost always categorized alongside peptides (like Ipamorelin or BPC-157) formarketing and search relevance, it is actually a non-peptide spiroindoline. This is the exact reason itsurvives stomach acid and can be taken orally, unlike true peptides which must be injected.

Because it has a 24-hour half-life, you only need to take it once a day. The timing depends on yourgoals: If you want to harness the massive hunger surge to eat more calories (bulking), take it in themorning. If you want to avoid the hunger and maximize the deep sleep benefits, take it immediatelybefore bed.

Yes, intracellular water retention is a very common side effect during the first few weeks of MK-677 use.This is often described as a "full" or "puffy" look. It is a natural response to elevated Growth Hormoneand typically subsides as the body adapts, though managing carbohydrate and sodium intake canheavily mitigate this.

It is a factor that must be managed. Elevated Growth Hormone naturally shifts the body's metabolism,which can elevate fasting blood sugar levels. Users should maintain a clean diet, engage in regularcardiovascular exercise, and monitor their blood glucose. Some users pair MK-677 with insulin-sensitizing supplements like Berberine.

No. Because it is an oral, non-peptide chemical compound (usually suspended in liquid or in capsuleform), it is highly stable. It should simply be stored at room temperature, away from extreme heat anddirect sunlight.

It may reduce insulin sensitivity in some individuals, making periodic monitoring of blood glucose advisable during prolonged use.

Some users report improved sleep and appetite within days, while changes in body composition, recovery, and muscle development generally require several weeks to months.

Research protocols sometimes combine MK-677 with growth hormone-releasing peptides or other regenerative peptides, although such combinations should only be considered under qualified medical supervision.

No. MK-677 has been investigated in clinical research but has not received FDA approval for general medical use.

MK-677 has been studied for age-related growth hormone decline, muscle wasting, bone health, recovery, sleep quality, and other conditions involving reduced GH secretion.

Certification Standards

Certified Vendor Requirements

To qualify as a PeptideValidation.com Certified Vendor, companies must meet our rigorous multi-step testing and documentation standards. Certification is not bought — it is earned through independent verification.

🏆 Apply for Certification

To qualify, vendors must:

  • 📦

    Submit Batch Testing

    Vendors must submit product samples for independent third-party lab testing before listing.

  • Pass Purity Requirements

    All products must meet minimum purity thresholds verified by HPLC analysis.

  • 🔬

    Verify Identity via LC-MS

    Molecular identity of each compound confirmed through liquid chromatography-mass spectrometry.

  • 📄

    Maintain Full Documentation

    COAs, batch records, and testing documentation must be publicly available on the vendor profile.

  • 🔄

    Undergo Quarterly Re-Testing

    Certification requires mandatory re-testing every quarter to maintain active certified status.

🔒 PeptideValidation.com does not sell peptides

Looking for Certified Peptide Sources?

Access our directory of independently reviewed and tested vendors who meet our rigorous testing and validation standards.

PeptideValidation.com is an independent testing and certification platform. We do not sell peptides or receive commission from vendors.

Access Certified Vendor Directory
6+
Testing Methods
100%
Independent Testing
Q4
Quarterly Reviews